While healthy HSC are more sensitive to CsA in the absence of IM (as they lack the pro-survival signalling from BCR-ABL1 TK), the combination of CsA and IM increases cell death in CML CFC. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.